|
US4745104A
(en)
*
|
1985-04-15 |
1988-05-17 |
The Regents Of The University Of California |
Pseudopterosin and synthetic derivatives thereof
|
|
US4849410A
(en)
*
|
1985-04-15 |
1989-07-18 |
The Regents Of The University Of California |
Pseudopterosin and synthetic derivatives thereof
|
|
JPS63146839A
(ja)
|
1986-12-11 |
1988-06-18 |
Toa Nenryo Kogyo Kk |
プテロシン系化合物を含んで成る制癌剤
|
|
JPH02237932A
(ja)
*
|
1989-03-10 |
1990-09-20 |
Yokichi Mochizuki |
結石等の治療剤
|
|
US5439936A
(en)
*
|
1989-10-03 |
1995-08-08 |
The Regents Of The University Of California |
Method of treating certain tumors using illudin analogs
|
|
HU224548B1
(hu)
*
|
1993-04-07 |
2005-10-28 |
Taiho Pharmaceutical Co. Ltd. |
Tiazolidinszármazékok és ezeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
|
|
DE69719544T2
(de)
|
1996-12-12 |
2003-11-06 |
Banyu Pharmaceutical Co., Ltd. |
Pyrazolderivate
|
|
FR2777566B1
(fr)
*
|
1998-04-15 |
2003-02-21 |
Synthelabo |
Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
|
|
IL156445A0
(en)
*
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
|
AR036237A1
(es)
*
|
2001-07-27 |
2004-08-25 |
Bayer Corp |
Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento
|
|
DE10142666A1
(de)
*
|
2001-08-31 |
2003-03-20 |
Aventis Pharma Gmbh |
Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
|
|
DE10142668A1
(de)
*
|
2001-08-31 |
2003-03-20 |
Aventis Pharma Gmbh |
Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
|
|
US6797287B2
(en)
*
|
2001-09-25 |
2004-09-28 |
Pharmachem Laboratories, Inc. |
Phaseolamin compositions and methods for using the same
|
|
CA2703698C
(en)
*
|
2002-04-30 |
2016-11-22 |
Unigen Pharmaceuticals, Inc. |
Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
|
|
AU2003287965A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Carex Sa |
Modulation of peroxisome proliferator activated receptors activity
|
|
AU2003277576A1
(en)
*
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
JP4594611B2
(ja)
*
|
2002-11-08 |
2010-12-08 |
武田薬品工業株式会社 |
受容体機能調節剤
|
|
FR2849849B1
(fr)
*
|
2003-01-13 |
2006-08-04 |
Merck Sante Sas |
Nouveaux acides carboxyliques et derives pour le traitement et la prevention du diabete et des dyslipemies
|
|
EP1596877A4
(en)
*
|
2003-02-26 |
2007-07-25 |
Unigen Pharmaceuticals Inc |
FORMULATION FOR USE IN THE PREVENTION AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY CARBOHYDRATES
|
|
CA2541212A1
(en)
*
|
2003-11-04 |
2005-05-19 |
Wallace T. Ashton |
Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
EA011671B1
(ru)
*
|
2004-06-04 |
2009-04-28 |
Арена Фармасьютикалз, Инк. |
Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств
|
|
WO2006062933A2
(en)
*
|
2004-12-06 |
2006-06-15 |
Reliant Pharmaceuticals, Inc. |
Stable compositions of fenofibrate with fatty acid esters
|
|
FR2880885B1
(fr)
*
|
2005-01-14 |
2009-01-30 |
Merck Sante Soc Par Actions Si |
Derives d'acide phenylbenzoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
|
KR20070107108A
(ko)
*
|
2005-02-05 |
2007-11-06 |
아스트라제네카 아베 |
화학적 화합물
|
|
US7582803B2
(en)
*
|
2005-09-14 |
2009-09-01 |
Amgen Inc. |
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
|
|
US20080200458A1
(en)
*
|
2007-01-18 |
2008-08-21 |
Joseph Barbosa |
Methods and compositions for the treatment of body composition disorders
|